ACMR vs LRCX: stock comparison and AI forecast
Acm Research, Inc. (ACMR) and Lam Research Corp (LRCX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACMR Acm Research, Inc.
- Price
- $44.61 -24.6% · 6M
- Market Cap
- $3.11B
- P/E Ratio
- 21.2x
- Size
- mid-cap
- AI Forecast
LRCX Lam Research Corp
- Price
- $200.44 -30.0% · 6M
- Market Cap
- $250.38B
- P/E Ratio
- 29.9x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- LRCX is 80.6 times larger than ACMR by market capitalization ($250.38B against $3.11B).
- ACMR trades at 21.2 times trailing earnings, LRCX at 29.9 times.
- Over the last six months ACMR returned -24.6% and LRCX -30.0%.
- LRCX turns 33.2% of its revenue into net income, against 10.2% for ACMR.
- LRCX carries 0.89 times debt per unit of equity, against 0.59 times for ACMR.
- LRCX yields 0.52% in dividends; ACMR pays none.
- Both companies share the SEC industry classification Special Industry Machinery, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACMR | LRCX |
|---|---|---|
| Market Cap | $3.11B | $250.38B |
| P/E Ratio | 21.24x | 29.87x |
| P/B Ratio | 1.64x | 18.00x |
| Dividend Yield | – | 0.52% |
| EPS | $2.10 | $6.71 |
| Book Value/Share | $27.22 | $11.13 |
| Revenue/Share | $16.31 | $20.92 |
| FCF/Share | $-2.85 | $5.23 |
Profitability & Margins
| Metric | ACMR | LRCX |
|---|---|---|
| ROE | 6.1% | 65.7% |
| ROA | 3.2% | 34.7% |
| ROIC | 6.2% | 50.7% |
| Gross Margin | 43.5% | 28.1% |
| Operating Margin | 14.5% | 35.1% |
| Net Margin | 10.2% | 33.2% |
| EBT Margin | 17.1% | 35.3% |
| Tax Rate | 13.2% | 13.0% |
Financial Health
| Metric | ACMR | LRCX |
|---|---|---|
| Current Ratio | 3.16x | 2.48x |
| Quick Ratio | 2.28x | 1.86x |
| D/E Ratio | 0.59x | 0.89x |
| Financial Leverage | 1.89x | 1.89x |
| Interest Coverage | 35.3x | 16.1x |
| Working Capital | $2.08B | $10.81B |
Cash Flow
| Metric | ACMR | LRCX |
|---|---|---|
| Operating Cash Flow | -$72M | $7.58B |
| Free Cash Flow | -$199M | $6.54B |
| Capital Spending | -$126M | -$1.04B |
| OCF Growth YoY | -263.3% | 18.7% |
| FCF Growth YoY | – | 5.2% |
| FCF/Sales | -17.5% | 25.0% |
| CapEx/Sales | 11.1% | 4.0% |
Operational Efficiency
| Metric | ACMR | LRCX |
|---|---|---|
| Asset Turnover | 0.32x | 0.99x |
| Receivables Turnover | 1.6x | 4.6x |
| Inventory Turnover | 0.8x | 4.1x |
| Fixed Assets Turnover | 2.7x | 8.5x |
| Days Sales Outstanding | 226 days | 79 days |
| Days Inventory | 484 days | 88 days |
| Payables Period | – | 31 days |
| Cash Conversion Cycle | – | 136 days |
Income Statement
| Metric | ACMR | LRCX |
|---|---|---|
| Total Revenue | $1.14B | $26.13B |
| Operating Income | $164M | $9.65B |
| Net Income | $116M | $9.13B |
| R&D Expense | $174M | $2.47B |
| SG&A Expense | $203M | $1.22B |
| Cost of Goods Sold | $642M | $18.80B |
Dividend & Shareholder Information
| Metric | ACMR | LRCX |
|---|---|---|
| Dividends Per Share | – | $1.04 |
| Payout Ratio | – | 15.5% |
| Shares Outstanding | 70M | 1249M |
| Net Income Growth | -1.1% | 47.0% |
| EPS Growth | 31.2% | 48.1% |
ACMR vs LRCX: stock comparison and AI forecast
Which is bigger, ACMR or LRCX?
LRCX is 80.6 times larger than ACMR by market capitalization ($250.38B against $3.11B).
Which is cheaper on earnings, ACMR or LRCX?
ACMR trades at 21.2 times trailing earnings, LRCX at 29.9 times.
Which stock performed better over the last six months, ACMR or LRCX?
Over the last six months ACMR returned -24.6% and LRCX -30.0%.
Which one does Intratio's AI model rank higher, ACMR or LRCX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.